Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine Augmentation in Early-Nonresponsive MDD
NCT04589143Phase 4Completed
- Sponsor
- Central South University
- Start
- Oct 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of agomelatine in major depressive disorder (MDD), sponsored by Central South University. Started Oct 2020; status: completed.
02
Drugs
agomelatine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04589143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04589143.